Semofull Injection | Semaglutide | GLP-1 Receptor Agonist | Diabetes & Weight Management Supplier
Semofull Injection contains Semaglutide, a GLP-1 receptor agonist used for the management of type 2 diabetes and weight control. It helps regulate blood sugar levels and supports weight reduction under medical supervision.
🔍 Keywords
Semaglutide Injection, GLP-1 Agonist, Type 2 Diabetes Treatment, Weight Loss Injection, Antidiabetic Medicine Supplier, Pharma Exporter India
🔹 Product Category
Specialty Medicine | Antidiabetic | GLP-1 Therapy
🔹 Composition
Semaglutide (strength as per COA)
🔹 Uses / Indications
✔ Type 2 Diabetes Mellitus
✔ Blood sugar control
✔ Weight management (as prescribed)
✔ Cardiometabolic support
🔹 Key Benefits
✔ Improves glycemic control
✔ Supports weight reduction
✔ Once-weekly dosing (typically)
✔ Widely used in modern diabetes care
🔹 Dosage & Administration
✔ Subcutaneous injection
✔ Administered as prescribed by physician
✔ Usually once weekly
🔹 Packaging & Supply
✔ Pre-filled pen / vial (as available)
✔ Cold-chain export packaging available
✔ Bulk supply supported
🔹 Storage Instructions
✔ Store at 2–8°C
✔ Do not freeze
✔ Protect from light
🔹 Certifications
✔ WHO-GMP Certified
✔ COA & COPP Available
🌍 Global Export Supply
USA, UK, UAE, Singapore, India, Philippines, Vietnam, South Africa, Nigeria, Kenya, Brazil, Mexico, Peru
📍 Location: Nagpur, Maharashtra, India
📞 Contact for Bulk Orders
+91 8007161282
+91 9970011496
📧 Email: sales@pacificmedicines.com
